Roots Analysis

FEBRUARY 29, 2024

Sutro Biopharma, a California based, clinical-stage company, announced initial safety data in ovarian cancer patients from its ongoing phase I study ( NCT03748186 ) of STRO-002. Sutro Biopharma, Inc., To get more insights into the ADCs development pipeline, check out the Biopharma detailed report here.

40

40

European Pharmaceutical Review

JULY 7, 2023

New recommendations to boost the competitiveness in UK biopharma and Medtech sectors have been published by Imperial College London. Technological solutions and policy recommendations for government have been identified as a way to help make sectors such as biopharma and Medtech more innovative and increase their value added.

Compounding 85

Compounding Pharmaceutical Companies Pharmaceutical Companies 85

pharmaphorum

JUNE 10, 2022

The digital revolution has already reshaped the commercial engine of biopharma companies. But most biopharma companies remain in an early phase of their digital journey while the window to drive significant competitive advantage closes. Biopharma organisations can no longer count on the status quo – just selling drugs and treatments.

Patient Care 132

Patient Care 132

PharmExec

AUGUST 22, 2022

How do procurement and finance leaders at biopharma companies plan for a future that has unknowns and uncertainty? Hear Werewolf Therapeutics share insights, lessons learned, and key decision points that allowed the company to build mission-aligned, transformative value.

52

52

European Pharmaceutical Review

DECEMBER 13, 2022

REGULATORY INSIGHT. Arnaud Robert and Brendan O’Callaghan, Sanofi. Patient-centred pharmaceutical packaging: are we there yet? Giana Carli Lorenzini, Technical University of Denmark. Interchangeability of biosimilars in the EU – the industry impact. Marie Manley and Chris Boyle, Sidley Austin LLP. DRUG DEVELOPMENT. UPSTREAM BIOPROCESSING.

Packaging 85

Packaging 85

European Pharmaceutical Review

MARCH 15, 2024

According to research published by Coherent Market Insights, the global mycoplasma testing market is anticipated to reach $1,907.6 million by 2031. The market is set to witness a compound annual growth rate (CAGR) of 9.7 percent during the forecast period, the report predicted. What is driving and limiting growth in the market?

Compounding 85

Compounding 85

pharmaphorum

OCTOBER 14, 2022

As the only industry-led forum providing biopharma with the insights necessary to make strategic and scientific decisions on their fibrosis pipeline, the 6th Antifibrotic Drug Development Summit returns to host the unmissable conversations transforming antifibrotic drug development research.

52

52

Pharmafile

FEBRUARY 22, 2023

Published date: 22/02/2023 Summary: · Edith Hessel, experienced R&D and biopharma executive, named as Chief Scientific Officer · Osteoporosis announced as first indication, driven by Relation’s proprietary engine for indication selection SelectomaticTM London, February 22, 2023 – Relation Therapeutics, a leader in the use of high-resolution biology, (..)

52

52

BioPharm

OCTOBER 19, 2022

Lorenzo De Benedictis provides insights and outlook on the future of single-use systems in Biopharma. SUS enables innovative process solutions around aseptic fluid management and improves aseptic liquid transfer in various manufacturing facilities. And yet there is hesitation.Dr.

40

40

BioPharm

OCTOBER 19, 2022

Lorenzo De Benedictis provides insights and outlook on the future of single-use systems in Biopharma. SUS enables innovative process solutions around aseptic fluid management and improves aseptic liquid transfer in various manufacturing facilities. And yet there is hesitation.Dr.

40

40

Viseven

OCTOBER 3, 2023

Veeva APAC Commerical Summit is one of the most prominent events in the Asia-Pacific region where leading companies in biopharma connect, share professional expertise, network, and have fun.

52

52

Impact Pharmaceutical Services

NOVEMBER 8, 2023

November 8, 2023, Boston, MA Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and biotechnology clients, announced today that it has been named a BioSpace 2024 Best Place to Work. Voting was conducted in August, 2023.

40

40

pharmaphorum

OCTOBER 20, 2022

Such scattered information is commonplace among brand teams; insights may be stored in various files and folders, which prevents collaboration and hinders teams from creating optimal brand strategies. In my experience working on global biopharma brands, commercial success is built on collaboration and solid basics.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Data Entry Documentation 98

Roots Analysis

FEBRUARY 28, 2024

On 28 October 2019, CARsgen Therapeutics , a clinical-stage biopharma company, announced that the FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to its investigational CT053 CAR-T cell therapy. How many CAR-T therapies are in development: There are currently more than 530+ CAR-T therapies in development.

Immunization 52

Immunization FDA 52

European Pharmaceutical Review

JANUARY 4, 2024

In the biopharma industry, prior to considering any IIoT applications, automation and digitalisation of operations must be implemented, according to expert insight gathered by the authors. The authors added that Sanofi acknowledged a need for employee training and support for such a transition at scale.

96

96

Pharmaceutical Technology

FEBRUARY 13, 2023

SOPHiA GENETICS’ platform can analyse data and produce insights from complex multimodal data sets and different diagnostic modalities. This collaboration aims to use the global SOPHiA DDM platform, a cloud-native platform of SOPHiA GENETICS, and multimodal algorithmic capabilities for AstraZeneca’s oncology portfolio.

52

52

Pharmaceutical Technology

SEPTEMBER 1, 2022

The GuardantINFORM clinical-genomic platform provides biopharma partners with an in-silico platform that merges de-identified longitudinal clinical data and genomic data obtained from the Guardant360 liquid biopsy test. This approach aids in expediting next-generation cancer therapy research and development.

64

64

Pharmaceutical Technology

JUNE 29, 2022

According to Laursen, the decision to break into speciality enzymes was based on a look into the future of the biopharma market and an important assessment of how the company believes it can make a genuine difference. The impact could be huge for the biopharma industry. That is a key competitive advantage,” says Laursen. “We

Pharmaceutical Companies 118

Pharmaceutical Companies Pharmaceutical Companies 118

pharmaphorum

OCTOBER 13, 2021

The Gastrointestinal Cancer Drug Development Summit is the only biopharma-led conference dedicated to identifying and progressing therapeutic opportunities in targeted and immunotherapies, ADCs, and precision oncology to address the large unmet clinical need in GI cancers. Register for your FREE ticket here: [link].

Immunization 52

Immunization 52

pharmaphorum

JUNE 2, 2022

However, unlike many consumer industries, biopharma, medical technology, and wellness companies have struggled to build meaningful personalized customer experiences. Today, biopharma and med tech executives are faced with numerous channels, novel technologies, and a high volume of data.

Communication 52

Communication FDA 52

pharmaphorum

JUNE 12, 2017

Biopharma companies must take into account a multitude of factors when considering physician prescribing behaviors, and need a more integrated "pull-through" strategy across their teams, from managed markets, to marketing, to field sales.

52

52

pharmaphorum

JUNE 9, 2021

closerlook’s skills and software products in data science, AI, and advanced analytics provide life science brands with real-time insights and the ability to develop hyper-targeted and precisely personalized campaigns at scale. Meet closerlook.

Communication 72

Communication 72

European Pharmaceutical Review

JUNE 15, 2023

According to a report by Future Market Insights, the small molecule innovator contract development and manufacturing organisation (CDMO) market is projected to value $48.09 Accelerating advancement of research and technology in biopharma are generating opportunities for the industry to develop innovative small molecule drugs.

Compounding 52

Compounding 52

pharmaphorum

APRIL 20, 2021

Network with 100+ executive biopharma leaders over 3-days of comprehensive insights to uncover the latest industry knowledge on the molecular heterogeneity of lung cancer, the implications for therapeutic design when considering acquired resistance and optimal application of new drugs in the clinic.

Medical Schools 52

Medical Schools Immunization 52

pharmaphorum

NOVEMBER 15, 2021

You don’t want to miss out on gaining exclusive insight from our esteemed speaker faculty: Jane Grogan, Graphite Bio. Ann Kapoun and Suba Krishnan Mereo, BioPharma. . • Plus 2 add on workshops: • Elucidating the anti-tumor immunity of other immune checkpoint inhibitors in oncology. Jeremy Waight and Marc Ballas, GlaxoSmithKline.

Medical Schools 52

Medical Schools Immunization Hospitals 52

pharmaphorum

SEPTEMBER 9, 2022

Around 80% of biopharma companies have set net zero or carbon neutrality targets, for example. It should be granular enough for asset-level insights, whether those assets be managed directly or by a supplier, and broad enough to inform company-level operational decisions. Advances in climate intelligence are making this possible.

Pharmaceutical Companies 104

Pharmaceutical Companies Pharmaceutical Companies Vaccines 104

pharmaphorum

NOVEMBER 20, 2020

LONDON, November 3, 2020 – Prescient , a biopharma product and portfolio strategy partner, announces the recent appointment of three new senior members: Gordon Gochenauer, Dr. Priya Kar and Dr. Cameron Mackenzie. Prescient hires three new senior members to expand its expertise and keep pace with the company’s growth.

Medical Schools 69

Medical Schools 69

Viseven

JUNE 12, 2023

The global pharmaceutical market is becoming more digitalized, insight-driven, and consumer-centric. I was there to provide insightful information on the latest trends in omnichannel marketing and explore novelties in the pharmaceutical industry,” says Yanxia Tang, Account Executive at Viseven.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 52

pharmaphorum

APRIL 22, 2021

Indigo Medical, a provider of material review, medical signatory approval services and medical communication for global pharmaceutical and biopharma companies, is joining imc group with the backing of pan-European investor Waterland Private Equity.

Communication 52

Communication 52

PharmaShots

APRIL 13, 2023

Shots: With the indispensable transformations carried out over the years, the biopharma industry witnessed miraculous changes in operations, technology, and innovation. To be relevant and productive in the era of perpetual innovation, biopharma companies are embracing every necessary aspect of the modern world. model, the pharma 4.0

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies Labelling 40

pharmaphorum

JUNE 15, 2021

COUCH Health works globally with pharma, biopharma, medical device companies and CROs, providing insights, patient recruitment, patient retention, and investigator site support. To learn more about COUCH Health, visit couchhealth.co. The post COUCH Health Engages Mark Duman as Chief Strategy Officer appeared first on.

52

52

Pharma Marketing Network

MARCH 25, 2022

Including caregiver insights and creating specific caregiver materials in the product development cycle is a good place for pharma to engage caregivers. Extension of the patient: expanding the role of caregivers in biopharma development. Findings note that caregivers are a vital source of information. Sunny White. Whiting CG, Wong SL.

Labelling 98

Labelling FDA 98

pharmaphorum

JANUARY 10, 2023

Other new insights and contributions include those of Astellas, The Clinical UX Association, Haleon, and Amryt Pharma. Regarding the latter, it was announced this week that biopharma and healthcare group Chiesi Farmaceutici S.p.A. is to acquire the 2015-established Amryt Pharma Plc. in an all-cash transaction worth up to $1.48

52

52

Roots Analysis

OCTOBER 4, 2023

For detailed insights about this domain, check out our report Bispecific Antibodies Market. I would like to highlight that; I have also pasted information on the approved drugs that are currently being evaluated in Phase III trials for different target indications. during the period 2023-2035. during the period 2023-2035.

Chemotherapy 40

Chemotherapy Immunization FDA 40

Pharmaceutical Technology

AUGUST 10, 2022

According to Jayna Blake, at Baxter BioPharma Solutions (BPS), the need for demonstrable performance and expertise from an established CMO should be at the top of any sponsor’s list of requirements. For more information about how Baxter BioPharma Solutions manufacturing expertise can support your project, download the presentation below.?.

Packaging 52

Packaging Communication 52

pharmaphorum

SEPTEMBER 8, 2021

In a letter to The Daily Telegraph newspaper with AZ’s head of biopharma R&D Mene Pangalos, Soriot write that the UK is only a few weeks away from having a definitive answer on whether two doses of COVID-19 vaccines can provide “continued, protective immunity.”

Vaccines 83

Vaccines Immunization Hospitals 83

Pharmaceutical Technology

SEPTEMBER 8, 2022

The speciality drug channel participants, including speciality pharmacies, biopharma companies, and distributors, are transforming their operations with automated and secure data systems and next-generation analytics, which will improve data collection, partner performance and strategy effectiveness. Discover the top speciality pharmacies.

Documentation 45

Documentation Clinic Management Communication Patient Care 45